29 employees
TenSixteen Bio is a biotechnology company focused on developing novel therapeutics for a variety of diseases.
2020
$40M
from 2 investors over 2 rounds
TenSixteen Bio raised $40M on January 27, 2022
Investors: GV and Foresite Capital